Life Science Investing Accent Trial Data Demonstrates that Narmafotinib + Chemotherapy Combination Superior to Chemotherapy Alone
Biotech Investing Radiopharm Theranostics Accelerates 177Lu-RAD204 Phase 1 Dose Escalation Clinical Trial Based on Positive Recommendation from Data Safety and Monitoring Committee
Biotech Investing Radiopharm Theranostics to Participate in the D. Boral Capital Inaugural Global Conference
Precious Metals & Critical Minerals Hybrid Investor Conference: Presentations Now Available for Online Viewing